Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CBOE✓SelectedUSD · CBOEGSK vs CBOE performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs CBOE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
CBOE return
+108.8%
Excess return
-56.1%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioCBOEExcessAlpha
1D-0.1%0.0%-0.1%-0.1%
7D-5.3%-4.7%-0.6%-5.1%
30D-3.7%+12.2%-15.9%-4.3%
3M-7.3%+22.0%-29.2%-8.2%
6M-4.2%-0.4%-3.8%-4.0%
YTD+0.9%+43.6%-42.7%-2.1%
1Y+7.3%+41.1%-33.9%+4.3%
3Y+52.7%+108.1%-55.4%+47.9%
All+52.7%+108.8%-56.1%+47.9%

Cumulative growth

Daily Returns

Daily percentage return beside CBOE.

Daily Out/Under-Performance

Portfolio return minus CBOE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CBOE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded CBOE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling